Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-05-30 20:55:50 UTC |
---|
HMDB ID | HMDB0000070 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Pipecolic acid |
---|
Description | Pipecolic acid is a metabolite of lysine found in human physiological fluids such as urine, plasma and CSF. However, it is uncertain if pipecolic acid originates directly from food intake or from mammalian or intestinal bacterial enzyme metabolism. Recent studies suggest that plasma pipecolic acid, particularly the D-isomer, originates mainly from the catabolism of dietary lysine by intestinal bacteria rather than by direct food intake. In classic Zellweger syndrome (a cerebro-hepato-renal genetic disorder, OMIM 214100 ) pipecolic acid accumulate in the plasma of the patients. It is known that plasma pipecolic acid levels are also elevated in patients with chronic liver diseases. Pipecolic acid is moderately elevated in patients with pyridoxine-dependent seizures and might therefore be a possible biochemical marker for selecting candidates for pyridoxine therapy (Plecko et al 2000). Pipecolic acid was also elevated in CSF in these vitamin B6-responsive patients (PMID 12705501 ). Pipecolic acid is found to be associated with adrenoleukodystrophy, infantile Refsum disease, and peroxisomal biogenesis defect, which are also inborn errors of metabolism. Pipecolic acid is a biomarker for the consumption of dried and cooked beans. |
---|
Structure | InChI=1S/C6H11NO2/c8-6(9)5-3-1-2-4-7-5/h5,7H,1-4H2,(H,8,9) |
---|
Synonyms | Value | Source |
---|
2-Piperidinecarboxylic acid | ChEBI | Homoproline | ChEBI | Pipecolinic acid | ChEBI | 2-Piperidinecarboxylate | Generator | Pipecolinate | Generator | Pipecolate | Generator | ()-Piperidine-2-carboxylic acid | HMDB | (+/-)-2-piperidinecarboxylate | HMDB | (+/-)-2-piperidinecarboxylic acid | HMDB | (+/-)-pipecolate | HMDB | (+/-)-pipecolic acid | HMDB | (+/-)-pipecolinate | HMDB | (+/-)-pipecolinic acid | HMDB | (.+/-.)-2-piperidinecarboxylic acid | HMDB | (RS)-2-Piperidinecarboxylate | HMDB | (RS)-2-Piperidinecarboxylic acid | HMDB | .alpha.-pipecolinic acid | HMDB | 2-Carboxypiperidine | HMDB | 2-Pipecolinic acid | HMDB | 2-Piperidinylcarboxylic acid | HMDB | a-Pipecolinate | HMDB | a-Pipecolinic acid | HMDB | Acide pipecolique | HMDB | Acide piperidine-carboxylique-2 | HMDB | alpha-Pipecolinate | HMDB | alpha-Pipecolinic acid | HMDB | Dihydrobaikiane | HMDB | DL-2-Piperidinecarboxylate | HMDB | DL-2-Piperidinecarboxylic acid | HMDB | DL-Homoproline | HMDB | DL-Pipecolate | HMDB, Generator | DL-Pipecolic acid | HMDB | DL-Pipecolinate | HMDB | DL-Pipecolinic acid | HMDB | hexahydro-2-Picolinate | HMDB | hexahydro-2-Picolinic acid | HMDB | Hexahydropicolinate | HMDB | Hexahydropicolinic acid | HMDB | Pipecolic acid free base | HMDB | Piperidine-2-carboxylic acid | HMDB | Piperolinate | HMDB | Piperolinic acid | HMDB | L-Pipecolic acid | MeSH, HMDB | Pipecolic acid, (R)-isomer | MeSH, HMDB | Pipecolic acid, ion (1-) | MeSH, HMDB | Pipecolic acid, monopotassium salt | MeSH, HMDB | Pipecolic acid hydrochloride, (+-)-isomer | MeSH, HMDB | Pipecolic acid, (S)-isomer | MeSH, HMDB | Pipecolic acid, 14C-labeled CPD, (+,-)-isomer | MeSH, HMDB | Homopipecolic acid | MeSH, HMDB | Pipecolic acid, (+,-)-isomer | MeSH, HMDB | Pipecolic acid, ion(1-), (+,-)-isomer | MeSH, HMDB | Pipecolic acid, ion(1-), (S)-isomer | MeSH, HMDB | Piperidine-2-carboxylate | Generator, HMDB | Pipecolic acid | MeSH |
|
---|
Chemical Formula | C6H11NO2 |
---|
Average Molecular Weight | 129.157 |
---|
Monoisotopic Molecular Weight | 129.078978601 |
---|
IUPAC Name | piperidine-2-carboxylic acid |
---|
Traditional Name | (+,-)-pipecolic acid |
---|
CAS Registry Number | 535-75-1 |
---|
SMILES | OC(=O)C1CCCCN1 |
---|
InChI Identifier | InChI=1S/C6H11NO2/c8-6(9)5-3-1-2-4-7-5/h5,7H,1-4H2,(H,8,9) |
---|
InChI Key | HXEACLLIILLPRG-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Alpha amino acids |
---|
Alternative Parents | |
---|
Substituents | - Alpha-amino acid
- Piperidinecarboxylic acid
- Piperidine
- Amino acid
- Azacycle
- Organoheterocyclic compound
- Secondary amine
- Monocarboxylic acid or derivatives
- Secondary aliphatic amine
- Carboxylic acid
- Hydrocarbon derivative
- Organopnictogen compound
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Amine
- Organic nitrogen compound
- Organic oxide
- Aliphatic heteromonocyclic compound
|
---|
Molecular Framework | Aliphatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 264 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 314 mg/mL | Not Available | LogP | -2.31 | TSAI,RS ET AL. (1991) |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Pipecolic acid,1TMS,isomer #1 | C[Si](C)(C)OC(=O)C1CCCCN1 | 1263.2 | Semi standard non polar | 33892256 | Pipecolic acid,1TMS,isomer #2 | C[Si](C)(C)N1CCCCC1C(=O)O | 1344.1 | Semi standard non polar | 33892256 | Pipecolic acid,2TMS,isomer #1 | C[Si](C)(C)OC(=O)C1CCCCN1[Si](C)(C)C | 1356.9 | Semi standard non polar | 33892256 | Pipecolic acid,2TMS,isomer #1 | C[Si](C)(C)OC(=O)C1CCCCN1[Si](C)(C)C | 1394.2 | Standard non polar | 33892256 | Pipecolic acid,2TMS,isomer #1 | C[Si](C)(C)OC(=O)C1CCCCN1[Si](C)(C)C | 1694.1 | Standard polar | 33892256 | Pipecolic acid,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C1CCCCN1 | 1497.9 | Semi standard non polar | 33892256 | Pipecolic acid,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1CCCCC1C(=O)O | 1572.1 | Semi standard non polar | 33892256 | Pipecolic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C1CCCCN1[Si](C)(C)C(C)(C)C | 1842.5 | Semi standard non polar | 33892256 | Pipecolic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C1CCCCN1[Si](C)(C)C(C)(C)C | 1813.2 | Standard non polar | 33892256 | Pipecolic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C1CCCCN1[Si](C)(C)C(C)(C)C | 1963.5 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Pipecolic acid GC-EI-TOF (Non-derivatized) | splash10-0a4i-0910000000-d9cfd443adb5187a3f21 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Pipecolic acid GC-EI-TOF (Non-derivatized) | splash10-0a4i-0910000000-d9cfd443adb5187a3f21 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Pipecolic acid GC-EI-TOF (Non-derivatized) | splash10-0a4i-0910000000-d9cfd443adb5187a3f21 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Pipecolic acid GC-EI-TOF (Non-derivatized) | splash10-0a4i-0910000000-d9cfd443adb5187a3f21 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pipecolic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-001i-9200000000-5c4f6059bcc868ca23fd | 2016-09-22 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pipecolic acid GC-MS (1 TMS) - 70eV, Positive | splash10-05fu-9700000000-8003521353d4d37af49f | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pipecolic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pipecolic acid GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pipecolic acid GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pipecolic acid GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Pipecolic acid Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-0060-9900000000-c5b5bf28424d5d5d1bda | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pipecolic acid Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-001i-9000000000-92660ad26bff36fba7ef | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pipecolic acid Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-0a59-9000000000-b779372fa816467754c1 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pipecolic acid LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Positive-QTOF | splash10-001i-9300000000-26dee47121401990f1c1 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pipecolic acid LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) 30V, Positive-QTOF | splash10-001i-9000000000-929057dfd61546bee24d | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pipecolic acid LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Negative-QTOF | splash10-004i-0900000000-6595801dc6a322f712f0 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pipecolic acid LC-ESI-QTOF , negative-QTOF | splash10-004i-0900000000-6595801dc6a322f712f0 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pipecolic acid , negative-QTOF | splash10-004i-0900000000-99a7a942cee58c76115a | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pipecolic acid LC-ESI-QTOF , positive-QTOF | splash10-001i-9300000000-26dee47121401990f1c1 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pipecolic acid LC-ESI-QTOF , positive-QTOF | splash10-001i-9000000000-929057dfd61546bee24d | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pipecolic acid , positive-QTOF | splash10-001i-9600000000-9631d0fbc984509f8d1e | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pipecolic acid 30V, Positive-QTOF | splash10-001i-9000000000-b244255a58ffb3b92be5 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pipecolic acid 35V, Positive-QTOF | splash10-001i-9000000000-c3041e7b5b1f5118c1ec | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pipecolic acid 10V, Positive-QTOF | splash10-001i-3900000000-b2ceb4c88f50a6524604 | 2015-05-27 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pipecolic acid 20V, Positive-QTOF | splash10-001i-9400000000-d3fab76e3fbfbe92c14d | 2015-05-27 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pipecolic acid 40V, Positive-QTOF | splash10-0a5c-9000000000-20464a5c62992da01ab7 | 2015-05-27 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pipecolic acid 10V, Negative-QTOF | splash10-004i-2900000000-6fac2bf48ffe4d910118 | 2015-05-27 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pipecolic acid 20V, Negative-QTOF | splash10-003r-8900000000-81b6d69c7a568e36b49f | 2015-05-27 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pipecolic acid 40V, Negative-QTOF | splash10-001i-9000000000-6332d1986eb0da0057fd | 2015-05-27 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pipecolic acid 10V, Negative-QTOF | splash10-004i-0900000000-b487cd2a72f17977a8cd | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pipecolic acid 20V, Negative-QTOF | splash10-01t9-1900000000-83b59287dc6d3e726326 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pipecolic acid 40V, Negative-QTOF | splash10-0036-9200000000-3ca813e7348e686ed922 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pipecolic acid 10V, Positive-QTOF | splash10-001i-9300000000-cb8df30f7267d610fd8d | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pipecolic acid 20V, Positive-QTOF | splash10-001i-9000000000-72c8691eb15dce6e0abb | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pipecolic acid 40V, Positive-QTOF | splash10-053r-9000000000-c7623c5058ad6c879ec3 | 2021-09-22 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Quadrupole Ion Trap, ESI+, Adduct: [M+H]+) | 2022-02-11 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | - Amniotic Fluid
- Blood
- Cerebrospinal Fluid (CSF)
- Feces
- Saliva
- Urine
|
---|
Tissue Locations | - Intestine
- Liver
- Placenta
- Prostate
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Amniotic Fluid | Detected and Quantified | 4.65 (2.24 - 8.40) uM | Not Specified | Both | Normal | | details | Blood | Detected and Quantified | 2.46 +/- 1.26 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0-5 uM | Newborn (0-30 days old) | Both | Normal | | details | Blood | Detected and Quantified | 0-5 uM | Infant (1 - 3 months old) | Both | Normal | | details | Blood | Detected and Quantified | 5.73 (3.75 - 10.8) uM | Newborn (0-30 days old) | Both | Normal | | details | Blood | Detected and Quantified | 0-10 uM | Children (3 months - 6 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0-10 uM | Children (6 - 18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 1.46 (0.70-2.46) uM | Newborn (0-30 days old) | Both | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | <4 uM | Children (1-13 years old) | Not Specified | Normal | | details | Blood | Detected and Quantified | 2.0 +/- 0.8 uM | Infant (0-1 year old) | Not Specified | Normal | | details | Blood | Detected and Quantified | 0.4-4.9 uM | Infant (0-1 year old) | Not Specified | Normal | | details | Blood | Detected and Quantified | <2.323 uM | Children (1 - 13 years old) | Male | Normal | | details | Blood | Detected and Quantified | <3 uM | Children (1 - 13 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.540-2.460 uM | Newborn (0-30 days old) | Both | Normal | | details | Blood | Detected and Quantified | 0.774-54.198 uM | Children (1-13 years old) | Both | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 10.0 (0.0-20.0) uM | Children (1-13 years old) | Both | Normal | | details | Blood | Detected and Quantified | 1.20 +/- 0.11 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Female | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.75 (0.0-1.5) uM | Adult (>18 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | <1.5 uM | Children (1 - 13 years old) | Male | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.056 (0.009 - 0.120) uM | Adult (>18 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.08 (0.07-0.10) uM | Adult (>18 years old) | Not Specified | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.017 +/- 0.005 uM | Adult (>18 years old) | Not Specified | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | <1.6 uM | Children (1-13 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0-0.15 uM | Children (0 - 10 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0-0.15 uM | Adolescent (>11 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected and Quantified | 61.166 +/- 74.328 nmol/g wet feces | Not Specified | Not Specified | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 0.28 (0.0-0.56) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.03 +/-0.07 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.032 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | <0.565 umol/mmol creatinine | Children (1 - 13 years old) | Male | Normal | | details | Urine | Detected and Quantified | <6 umol/mmol creatinine | Children (1-13 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 0.15 (0.14-0.24) umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | Urine | Detected and Quantified | < 0.566 umol/mmol creatinine | Not Available | Not Available | Normal | | details | Urine | Detected and Quantified | 0 - 25.33 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | Urine | Detected and Quantified | 0 - 13.91 umol/mmol creatinine | Infant (1 - 6 months old) | Both | Normal | | details | Urine | Detected and Quantified | 0 - 5.09 umol/mmol creatinine | Infant (6 months - <1 year old) | Both | Normal | | details | Urine | Detected and Quantified | 0 - 0.64 umol/mmol creatinine | Children (1 - 2 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0 - 0.64 umol/mmol creatinine | Children (2 - 4 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0 - 0.64 umol/mmol creatinine | Children (4 - 13 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0 - 0.64 umol/mmol creatinine | Adolescent (13 - 21 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0 - 0.64 umol/mmol creatinine | Adult (>21 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.03 +/- 0.07 umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 39.6 uM | Infant (0-1 year old) | Both | Infantile Refsum disease | | details | Blood | Detected and Quantified | 79.0 (5.0 - 378.0) uM | Adult (>18 years old) | Both | Peroxisomal biogenesis defect | | details | Blood | Detected and Quantified | 2.8-23 uM | Infant (0-1 year old) | Not Specified | Pyridoxine dependency with seizures (PDE) | | details | Blood | Detected and Quantified | 2.3 uM | Infant (0-1 year old) | Male | Pseudo Zellweger->D-bifunctional protein deficiency | | details | Blood | Detected and Quantified | 0-1.66 uM | Children (1-13 years old) | Both | Pseudoneonatal adrenoleukodystrophy | | details | Blood | Detected and Quantified | 4.1 uM | Newborn (0-30 days old) | Female | Rhizomelic chondrodysplasia punctata | | details | Blood | Detected and Quantified | 9.22 uM | Newborn (0-30 days old) | Not Specified | Zellweger syndrome | | details | Blood | Detected and Quantified | 21 uM | Infant (0-1 year old) | Male | Peroxisomal biogenesis disorder | | details | Blood | Detected and Quantified | <3.871 uM | Children (1-13 years old) | Not Specified | Adrenoleukodystrophy, X-linked | | details | Blood | Detected and Quantified | <3.871 uM | Infant (0-1 year old) | Not Specified | Refsum disease, classic, adult-onset | | details | Blood | Detected and Quantified | 0-1.660 uM | Newborn (0-30 days old) | Not Specified | Neonatal adrenoleukodystrophy | | details | Blood | Detected and Quantified | 0-38.713 uM | Children (1-13 years old) | Not Specified | Refsum disease, juvenile | | details | Blood | Detected and Quantified | 15-64 uM | Children (1 - 13 years old) | Male | Infantile Refsum disease | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Schizophrenia | | details | Blood | Detected and Quantified | 170.335-185.820 uM | Children (1-13 years old) | Not Specified | Refsum disease, infantile | | details | Blood | Detected and Quantified | 232.275-363.898 uM | Children (1-13 years old) | Male | Peroxisomal disorders, new type, liver | | details | Blood | Detected and Quantified | 26.325-216.790 uM | Infant (0-1 year old) | Both | Zellweger syndrome | | details | Blood | Detected and Quantified | 27.0988-162.593 uM | Newborn (0-30 days old) | Both | Neonatal adrenoleukodystrophy | | details | Blood | Detected and Quantified | 38.712-154.85 uM | Children (1 - 13 years old) | Male | Infantile Refsum's disease | | details | Blood | Detected and Quantified | 4.120-280 uM | Newborn (0-30 days old) | Female | Peroxisomal biogenesis disorder | | details | Blood | Detected and Quantified | 60.860-62.100 uM | Children (1-13 years old) | Female | Peroxisomal biogenesis disorder | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 1.8 uM | Infant (0-1 year old) | Both | Infantile Refsum disease | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | <0.5 - 3.5 uM | Children (1 - 13 years old) | Male | Infantile Refsum disease | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.053 (0.023-0.083) uM | Adult (>18 years old) | Both | Brain injury | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.19 (0.17-0.21) uM | Adult (>18 years old) | Not Specified | Malaria | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.38 (0.11-1.26) uM | Not Specified | Not Specified | Anemia | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.18 (0.14-0.22) uM | Not Specified | Not Specified | Malaria | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.17 (0.12-0.23) uM | Not Specified | Not Specified | Tuberculous meningitis | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.06 (0.02-0.26) uM | Adult (>18 years old) | Not Specified | Malaria | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 24-33 uM | Children (1-13 years old) | Both | Hyperlysinemia I, familial | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.05 (0.02-0.09) uM | Children (1-13 years old) | Not Specified | Convulsions | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 1-2 uM | Children (1-13 years old) | Male | Hyperpipecolatemia | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 1.715 (0.33 - 3.10) uM | Adult (>18 years old) | Both | Peroxisomal biogenesis defect | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Periodontal Probing Depth | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Oral cancer | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Female | Breast cancer | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Not Specified | Pancreatic cancer | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Not Specified | Periodontal diseases | | details | Urine | Detected and Quantified | 2.0 umol/mmol creatinine | Infant (0-1 year old) | Both | Infantile Refsum disease | | details | Urine | Detected and Quantified | 3.3 (1.5-5.0) umol/mmol creatinine | Adult (>18 years old) | Both | Adrenoleukodystrophy | | details | Urine | Detected and Quantified | 49.4 (8.4-90.4) umol/mmol creatinine | Children (1-13 years old) | Both | Adrenoleukodystrophy (ALD) | | details | Urine | Detected and Quantified | 0.02-228.3 umol/mmol creatinine | Children (1-13 years old) | Not Specified | Zellweger Syndrome | | details | Urine | Detected and Quantified | 0-5.314 umol/mmol creatinine | Children (1 - 13 years old) | Male | Infantile Refsum disease | | details | Urine | Detected and Quantified | 0.93-70 umol/mmol creatinine | Children (1-13 years old) | Both | Pseudoneonatal adrenoleukodystrophy | | details | Urine | Detected and Quantified | 4.522 umol/mmol creatinine | Children (1-13 years old) | Male | Hyperpipecolatemia | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Schizophrenia | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Infantile Refsum's disease |
---|
- Poll-The BT, Saudubray JM, Ogier H, Schutgens RB, Wanders RJ, Schrakamp G, van den Bosch H, Trijbels JM, Poulos A, Moser HW, et al.: Infantile Refsum's disease: biochemical findings suggesting multiple peroxisomal dysfunction. J Inherit Metab Dis. 1986;9(2):169-74. [PubMed:2427795 ]
- Poulos A, Sharp P, Fellenberg AJ, Danks DM: Cerebro-hepato-renal (Zellweger) syndrome, adrenoleukodystrophy, and Refsum's disease: plasma changes and skin fibroblast phytanic acid oxidase. Hum Genet. 1985;70(2):172-7. [PubMed:2408988 ]
- G.Frauendienst-Egger, Friedrich K. Trefz (2017). MetaGene: Metabolic & Genetic Information Center (MIC: http://www.metagene.de). METAGENE consortium.
| Rhizomelic chondrodysplasia punctata |
---|
- Baumgartner MR, Poll-The BT, Verhoeven NM, Jakobs C, Espeel M, Roels F, Rabier D, Levade T, Rolland MO, Martinez M, Wanders RJ, Saudubray JM: Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Ann Neurol. 1998 Nov;44(5):720-30. [PubMed:9818927 ]
| Refsum's disease |
---|
- Poulos A, Sharp P, Fellenberg AJ, Danks DM: Cerebro-hepato-renal (Zellweger) syndrome, adrenoleukodystrophy, and Refsum's disease: plasma changes and skin fibroblast phytanic acid oxidase. Hum Genet. 1985;70(2):172-7. [PubMed:2408988 ]
| Peroxisomal disorders, new type, liver |
---|
- Mandel H, Espeel M, Roels F, Sofer N, Luder A, Iancu TC, Aizin A, Berant M, Wanders RJ, Schutgens RB: A new type of peroxisomal disorder with variable expression in liver and fibroblasts. J Pediatr. 1994 Oct;125(4):549-55. [PubMed:7931872 ]
- G.Frauendienst-Egger, Friedrich K. Trefz (2017). MetaGene: Metabolic & Genetic Information Center (MIC: http://www.metagene.de). METAGENE consortium.
| Pyridoxine-dependent epilepsy |
---|
- Plecko B, Paul K, Paschke E, Stoeckler-Ipsiroglu S, Struys E, Jakobs C, Hartmann H, Luecke T, di Capua M, Korenke C, Hikel C, Reutershahn E, Freilinger M, Baumeister F, Bosch F, Erwa W: Biochemical and molecular characterization of 18 patients with pyridoxine-dependent epilepsy and mutations of the antiquitin (ALDH7A1) gene. Hum Mutat. 2007 Jan;28(1):19-26. [PubMed:17068770 ]
| D-Bifunctional protein deficiency |
---|
- Watkins PA, Chen WW, Harris CJ, Hoefler G, Hoefler S, Blake DC Jr, Balfe A, Kelley RI, Moser AB, Beard ME, et al.: Peroxisomal bifunctional enzyme deficiency. J Clin Invest. 1989 Mar;83(3):771-7. [PubMed:2921319 ]
| Pseudoneonatal adrenoleukodystrophy |
---|
- Poll-The BT, Roels F, Ogier H, Scotto J, Vamecq J, Schutgens RB, Wanders RJ, van Roermund CW, van Wijland MJ, Schram AW, et al.: A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy). Am J Hum Genet. 1988 Mar;42(3):422-34. [PubMed:2894756 ]
| Traumatic brain injury |
---|
- Smythe GA, Poljak A, Bustamante S, Braga O, Maxwell A, Grant R, Sachdev P: ECNI GC-MS analysis of picolinic and quinolinic acids and their amides in human plasma, CSF, and brain tissue. Adv Exp Med Biol. 2003;527:705-12. [PubMed:15206793 ]
| Malaria |
---|
- Medana IM, Hien TT, Day NP, Phu NH, Mai NT, Chu'ong LV, Chau TT, Taylor A, Salahifar H, Stocker R, Smythe G, Turner GD, Farrar J, White NJ, Hunt NH: The clinical significance of cerebrospinal fluid levels of kynurenine pathway metabolites and lactate in severe malaria. J Infect Dis. 2002 Mar 1;185(5):650-6. Epub 2002 Feb 14. [PubMed:11865422 ]
- Medana IM, Day NP, Salahifar-Sabet H, Stocker R, Smythe G, Bwanaisa L, Njobvu A, Kayira K, Turner GD, Taylor TE, Hunt NH: Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria. J Infect Dis. 2003 Sep 15;188(6):844-9. Epub 2003 Sep 9. [PubMed:12964115 ]
| Anemia |
---|
- Medana IM, Day NP, Salahifar-Sabet H, Stocker R, Smythe G, Bwanaisa L, Njobvu A, Kayira K, Turner GD, Taylor TE, Hunt NH: Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria. J Infect Dis. 2003 Sep 15;188(6):844-9. Epub 2003 Sep 9. [PubMed:12964115 ]
| Tuberculous meningitis |
---|
- Medana IM, Day NP, Salahifar-Sabet H, Stocker R, Smythe G, Bwanaisa L, Njobvu A, Kayira K, Turner GD, Taylor TE, Hunt NH: Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria. J Infect Dis. 2003 Sep 15;188(6):844-9. Epub 2003 Sep 9. [PubMed:12964115 ]
| Convulsion |
---|
- Medana IM, Day NP, Salahifar-Sabet H, Stocker R, Smythe G, Bwanaisa L, Njobvu A, Kayira K, Turner GD, Taylor TE, Hunt NH: Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria. J Infect Dis. 2003 Sep 15;188(6):844-9. Epub 2003 Sep 9. [PubMed:12964115 ]
| Hyperlysinemia I, familial |
---|
- Tondo M, Calpena E, Arriola G, Sanz P, Martorell L, Ormazabal A, Castejon E, Palacin M, Ugarte M, Espinos C, Perez B, Perez-Duenas B, Perez-Cerda C, Artuch R: Clinical, biochemical, molecular and therapeutic aspects of 2 new cases of 2-aminoadipic semialdehyde synthase deficiency. Mol Genet Metab. 2013 Nov;110(3):231-6. doi: 10.1016/j.ymgme.2013.06.021. Epub 2013 Jul 6. [PubMed:23890588 ]
| Hyperpipecolatemia |
---|
- Gatfield PD, Taller E, Hinton GG, Wallace AC, Abdelnour GM, Haust MD: Hyperpipecolatemia: A new metabolic disorder associated with neuropathy and hepatomegaly: A case study. Can Med Assoc J. 1968 Dec 28;99(25):1215-33. [PubMed:5700850 ]
| Colorectal cancer |
---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| Perillyl alcohol administration for cancer treatment |
---|
- Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010 Mar;6(1):78-95. Epub 2009 Sep 10. [PubMed:20300169 ]
| Pancreatic cancer |
---|
- Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010 Mar;6(1):78-95. Epub 2009 Sep 10. [PubMed:20300169 ]
| Periodontal disease |
---|
- Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010 Mar;6(1):78-95. Epub 2009 Sep 10. [PubMed:20300169 ]
| Periodontal Probing Depth |
---|
- Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
| Peroxisomal biogenesis defect |
---|
- van den Berg GA, Breukelman H, Elzinga H, Trijbels JM, Monnens LA, Muskiet FA: Determination of pipecolic acid in urine and plasma by isotope dilution mass fragmentography. Clin Chim Acta. 1986 Sep 30;159(3):229-37. [PubMed:3769211 ]
- Baas JC, van de Laar R, Dorland L, Duran M, Berger R, Poll-The BT, de Koning TJ: Plasma pipecolic acid is frequently elevated in non-peroxisomal disease. J Inherit Metab Dis. 2002 Dec;25(8):699-701. [PubMed:12705501 ]
- Fujita T, Hada T, Higashino K: Origin of D- and L-pipecolic acid in human physiological fluids: a study of the catabolic mechanism to pipecolic acid using the lysine loading test. Clin Chim Acta. 1999 Sep;287(1-2):145-56. [PubMed:10509903 ]
- Baumgartner MR, Poll-The BT, Verhoeven NM, Jakobs C, Espeel M, Roels F, Rabier D, Levade T, Rolland MO, Martinez M, Wanders RJ, Saudubray JM: Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Ann Neurol. 1998 Nov;44(5):720-30. [PubMed:9818927 ]
- Budden SS, Kennaway NG, Buist NR, Poulos A, Weleber RG: Dysmorphic syndrome with phytanic acid oxidase deficiency, abnormal very long chain fatty acids, and pipecolic acidemia: studies in four children. J Pediatr. 1986 Jan;108(1):33-9. [PubMed:2418187 ]
- G.Frauendienst-Egger, Friedrich K. Trefz (2017). MetaGene: Metabolic & Genetic Information Center (MIC: http://www.metagene.de). METAGENE consortium.
| Adrenoleukodystrophy |
---|
- Poulos A, Sharp P, Fellenberg AJ, Danks DM: Cerebro-hepato-renal (Zellweger) syndrome, adrenoleukodystrophy, and Refsum's disease: plasma changes and skin fibroblast phytanic acid oxidase. Hum Genet. 1985;70(2):172-7. [PubMed:2408988 ]
- G.Frauendienst-Egger, Friedrich K. Trefz (2017). MetaGene: Metabolic & Genetic Information Center (MIC: http://www.metagene.de). METAGENE consortium.
| Schizophrenia |
---|
- Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25. [PubMed:22024767 ]
- Al Awam K, Haussleiter IS, Dudley E, Donev R, Brune M, Juckel G, Thome J: Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia. J Neural Transm (Vienna). 2015 Aug;122 Suppl 1:S111-22. doi: 10.1007/s00702-014-1224-0. Epub 2014 May 1. [PubMed:24789758 ]
|
|
---|
Associated OMIM IDs | - 266510 (Infantile Refsum's disease)
- 215100 (Rhizomelic chondrodysplasia punctata)
- 266500 (Refsum's disease)
- 266100 (Pyridoxine-dependent epilepsy)
- 261515 (D-Bifunctional protein deficiency)
- 264470 (Pseudoneonatal adrenoleukodystrophy)
- 248310 (Malaria)
- 238700 (Hyperlysinemia I, familial)
- 114500 (Colorectal cancer)
- 260350 (Pancreatic cancer)
- 170650 (Periodontal disease)
- 214100 (Peroxisomal biogenesis defect)
- 300100 (Adrenoleukodystrophy)
- 181500 (Schizophrenia)
|
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB000545 |
---|
KNApSAcK ID | C00001387 |
---|
Chemspider ID | 826 |
---|
KEGG Compound ID | C00408 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Pipecolic_acid |
---|
METLIN ID | 50 |
---|
PubChem Compound | 849 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 17964 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | MDB00000036 |
---|
Good Scents ID | rw1586071 |
---|
References |
---|
Synthesis Reference | Asher, Vikram; Becu, Christian; Anteunis, Marc J. O.; Callens, Roland. New synthesis of pipecolic acid and analogs. Tetrahedron Letters (1981), 22(2), 141-4. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762. [PubMed:19212411 ]
- Kawasaki H, Hori T, Nakajima M, Takeshita K: Plasma levels of pipecolic acid in patients with chronic liver disease. Hepatology. 1988 Mar-Apr;8(2):286-9. [PubMed:3356409 ]
- Chang YF: Lysine metabolism in the human and the monkey: demonstration of pipecolic acid formation in the brain and other organs. Neurochem Res. 1982 May;7(5):577-88. [PubMed:6811962 ]
- van den Berg GA, Breukelman H, Elzinga H, Trijbels JM, Monnens LA, Muskiet FA: Determination of pipecolic acid in urine and plasma by isotope dilution mass fragmentography. Clin Chim Acta. 1986 Sep 30;159(3):229-37. [PubMed:3769211 ]
- Medana IM, Hien TT, Day NP, Phu NH, Mai NT, Chu'ong LV, Chau TT, Taylor A, Salahifar H, Stocker R, Smythe G, Turner GD, Farrar J, White NJ, Hunt NH: The clinical significance of cerebrospinal fluid levels of kynurenine pathway metabolites and lactate in severe malaria. J Infect Dis. 2002 Mar 1;185(5):650-6. Epub 2002 Feb 14. [PubMed:11865422 ]
- Danks DM, Tippett P, Adams C, Campbell P: Cerebro-hepato-renal syndrome of Zellweger. A report of eight cases with comments upon the incidence, the liver lesion, and a fault in pipecolic acid metabolism. J Pediatr. 1975 Mar;86(3):382-7. [PubMed:1113225 ]
- Plecko B, Stockler-Ipsiroglu S, Paschke E, Erwa W, Struys EA, Jakobs C: Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy. Ann Neurol. 2000 Jul;48(1):121-5. [PubMed:10894227 ]
- Burton BK, Reed SP, Remy WT: Hyperpipecolic acidemia: clinical and biochemical observations in two male siblings. J Pediatr. 1981 Nov;99(5):729-34. [PubMed:7299546 ]
- Smythe GA, Poljak A, Bustamante S, Braga O, Maxwell A, Grant R, Sachdev P: ECNI GC-MS analysis of picolinic and quinolinic acids and their amides in human plasma, CSF, and brain tissue. Adv Exp Med Biol. 2003;527:705-12. [PubMed:15206793 ]
- Trijbels JM, Monnens LA, Melis G, van den Broekvan Essen M, Bruckwilder M: Localization of pipecolic acid metabolism in rat liver peroxisomes: probable explanation for hyperpipecolataemia in Zellweger syndrome. J Inherit Metab Dis. 1987;10(2):128-34. [PubMed:3116331 ]
- Thomas GH, Haslam RH, Batshaw ML, Capute AJ, Neidengard L, Ransom JL: Hyperpipecolic acidemia associated with hepatomegaly, mental retardation, optic nerve dysplasia and progressive neurological disease. Clin Genet. 1975 Nov;8(5):376-82. [PubMed:1204235 ]
- Medana IM, Day NP, Salahifar-Sabet H, Stocker R, Smythe G, Bwanaisa L, Njobvu A, Kayira K, Turner GD, Taylor TE, Hunt NH: Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria. J Infect Dis. 2003 Sep 15;188(6):844-9. Epub 2003 Sep 9. [PubMed:12964115 ]
- Lee HF, Mak SC, Wu FW, Chi CS, Huang SC: Zellweger syndrome: report of one case. Acta Paediatr Taiwan. 2001 Jan-Feb;42(1):53-6. [PubMed:11270189 ]
- Kok RM, Kaster L, de Jong AP, Poll-The B, Saudubray JM, Jakobs C: Stable isotope dilution analysis of pipecolic acid in cerebrospinal fluid, plasma, urine and amniotic fluid using electron capture negative ion mass fragmentography. Clin Chim Acta. 1987 Sep 30;168(2):143-52. [PubMed:3315316 ]
- Baas JC, van de Laar R, Dorland L, Duran M, Berger R, Poll-The BT, de Koning TJ: Plasma pipecolic acid is frequently elevated in non-peroxisomal disease. J Inherit Metab Dis. 2002 Dec;25(8):699-701. [PubMed:12705501 ]
- Dancis J, Hutzler J: Comparative rates of metabolism of pipecolic acid in several animal species. Comp Biochem Physiol B. 1982;73(4):1011-2. [PubMed:6817963 ]
- Fujita T, Hada T, Higashino K: Origin of D- and L-pipecolic acid in human physiological fluids: a study of the catabolic mechanism to pipecolic acid using the lysine loading test. Clin Chim Acta. 1999 Sep;287(1-2):145-56. [PubMed:10509903 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
---|